Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
Combinatietherapie beschermt tegen SARS-CoV-2-mutanten
okt 2021 | Virale infecties